Biotechnology Stocks II Dollar-cost Averaging for UroGen Pharma Ltd. (URGN)

Biotechnology Stocks II: Dollar-cost Averaging for UroGen Pharma Ltd. (URGN)

Dollar-cost averaging calculator assumes a $1,000 initial investment and a recurring $100 monthly investment.

All values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.

Dollar-cost Average Calculator
Monthly Investments
2017/06/30 - 2025/04/17
StockURGN
Initial Price$18.0600
Initial Investment$1,000.00
Recurring Monthly Investment$100.00
Initial # Shares Bought55.3710
DCA # Monthly Investments94
DCA Total Monthly Investments$9,400.00
DCA # Monthly Shares Bought591.300
DCA Total Investments$10,400.00
DCA Total # Shares646.671
Final Price$9.6700
DCA Final Value of Total # Shares$6,253.31
DCA Percent Return-39.87%
No DCA Total # Shares Bought55.3710
No DCA Final Value$535.44
DCA Final Value - No DCA Final Value ($)$5,717.88
DCA Final Value - No DCA Final Value (%)1,067.89%
Stock Return Calculator


Not enough prices to do computations.



URGN Performance Table and Chart

URGN Compare Returns with S&P 500

URGN Trendline Chart

URGN Moving Average Chart

URGN Stock Return Map - See Patterns of Gains and Losses

URGN Stock Returns/Purchase Dates